Transcatheter Pulmonary Valve (TPV) Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Transcatheter Pulmonary Valve (TPV) Therapy Market: By Product Type (Valves, Delivery System), By End Users (Hospitals, Cardiology Clinics, Ambulatory Surgical Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Description

Market Dynamics: Transcatheter Pulmonary Valve (TPV) Therapy Market

 

Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. Increase in the prevalence of congenital heart diseases is a key factor drive the growth of global transcatheter pulmonary valve therapy market. Moreover, prolonged effectiveness of transcatheter valves, increase in the R&D for the innovation of newer products, and change in lifestyle leads to increase in prevalence of cardiovascular diseases are anticipated to fuel the transcatheter pulmonary valve (TPV) therapy market over the forecast period. However, stringent regulatory guidelines, low target population, high cost of therapy, and lack of skilled professionals may restrain the growth of transcatheter pulmonary valve (TPV) therapy market.

 

Market Scope: Transcatheter Pulmonary Valve (TPV) Therapy Market

Global transcatheter pulmonary valve (TPV) therapy market is segmented on the basis of product type, end user, and region

 

Based on the product type, the market is segmented into the following:

 

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Cardiology Clinics
  • Ambulatory Surgical Centers

 

Based on the region, the market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

 Regional Analysis: Transcatheter Pulmonary Valve (TPV) Therapy Market

Geographically, global transcatheter pulmonary valve (TPV) therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America transcatheter pulmonary valve therapy market growth driven by rise in the prevalence of cardiovascular diseases, rise in R&D for the innovation of newer products, and increase in healthcare expenditure. Europe transcatheter pulmonary valve therapy market has a lucrative growth owing high adoption of newer devices, sophisticated healthcare infrastructure, and increase in the prevalence of cardiovascular diseases due to change in lifestyle are boost the market. Asia Pacific transcatheter pulmonary valve therapy market has a significant share, which is attributed to large patient population, development in R&D for the innovation of newer products, and development on healthcare infrastructure are propel the market. Latin America transcatheter pulmonary valve therapy market expected to present notable growth due to expansion of business by the companies and development in economic growth are fuel the market.

 

Competition Assessment: Transcatheter Pulmonary Valve (TPV) Therapy Market

Key players profiles in the global transcatheter pulmonary valve (TPV) therapy market include:

  • Venus MedTech (China)
  • Inova (U.S.)
  • Edward Lifesciences (U.S.)
  • Medtronic Plc. (Ireland)

 

Notable Market Developments: Transcatheter Pulmonary Valve (TPV) Therapy Market

  • In September 2016, Venus MedTech launched a clinical trial to support the CE mark approval in EU region for its Venus P transcatheter pulmonary valve used in the treatment of pulmonary regurgitation

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

  • Venus MedTech (China)
  • Inova (U.S.)
  • Edward Lifesciences (U.S.)
  • Medtronic Plc. (Ireland)

 

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX